Yong W B, Wang H, Zhu X M
Beijing Institute for Cancer Research.
Zhonghua Nei Ke Za Zhi. 1993 Feb;32(2):91-3.
60 cases of Hodgkin's lymphoma were treated with combined chemotherapy and radiotherapy. 35 cases (58.3%) achieved complete remission (CR) and 25 cases (41.7%) partial remission (PR). Five and ten-year survival rates were 55.2% and 47.7% for the entire group. The five and ten-year survival rates were better for patients with stage I (100% and 100%), stage II (69.1% and 62.1%), and stage III (71.5% and 59.6%) than for patients with stage IV (16.2% and 16.2%), better for CR patients (89.4% and 81.3%) than for PR patients (10.1% and 5%) and better for patients with lymphocyte predominating type (75% and 50%) and nodular sclerosis type (74.5% and 65.2%) than for patients with mixed cellularity type (37.7% and 37.7%) and lymphocyte depleted type (0% and 0%). The results show that the stage and histologic type of the disease, the CR rate and the age of the patients had significant effect on the survival of Hodgkin's lymphoma. In order to improve the prognosis, it is important to make diagnosis early and to achieve CR.
60例霍奇金淋巴瘤患者接受了联合化疗和放疗。35例(58.3%)达到完全缓解(CR),25例(41.7%)部分缓解(PR)。全组患者的5年和10年生存率分别为55.2%和47.7%。I期(100%和100%)、II期(69.1%和62.1%)和III期(71.5%和59.6%)患者的5年和10年生存率高于IV期患者(16.2%和16.2%),CR患者(89.4%和81.3%)的生存率高于PR患者(10.1%和5%),淋巴细胞为主型(75%和50%)和结节硬化型(74.5%和65.2%)患者的生存率高于混合细胞型(37.7%和37.7%)和淋巴细胞消减型(0%和0%)患者。结果表明,疾病的分期、组织学类型、CR率和患者年龄对霍奇金淋巴瘤的生存有显著影响。为改善预后,早期诊断并实现CR很重要。